Sort By:

COVID/Flu Vaccine

This is a phase 3 study to evaluate the safety, tolerability and immunogenicity (immune response) of the Flu-COVID combination compared to taking both vaccines separately. Everyone receives both a COVID and a Flu Vaccine.

You can contact our office at 501-500-4270 or fill out the short "Do You Qualify" Questionnaire to see if you qualify for this study. Please click "View Trial Details"

View Trial Details
Ages 18 - 64
Compensation* Up to $500 for study related time and travel
Study Topics COVID/Flu Vaccine for Healthy Adults

*Compensation for time and travel may be available to those who qualify.

RSV in Adults who have Type 1 or Type 2 Diabetes, Coronary Artery Disease (CAD), Congested Heart Failure (CHF) or those that have had Solid Organ Transplants

This is a Phase 3 study to evaluate the safety and effectiveness of an mRNA vaccine targeting Respiratory Syncytial Virus (RSV) in:

- People who have had Type 1 or Type 2 Diabetes.
OR
- People who have Coronary Artery Disease (CAD).
OR
- People who have Congested Heart Failure (CHF).
OR
- Those that have had a Solid Organ Transplant (Lung, Kidney, and Liver).

RSV (Respiratory Syncytial Virus) is a common cause of severe respiratory disease in immunocompromised adults, and in solid organ transplant recipients. RSV is associated with significant morbidity and mortality.

You can contact our office at 501-500-4270 or fill out the short "Do You Qualify" Questionnaire to see if you qualify for this study.

View Trial Details
Ages 18+
Compensation* Up to $3,000 for study related time and travel
Study Topics Evaluating a vaccine for RSV in Adults who have Type 1 or Type 2 Diabetes, Coronary Artery Disease (CAD), Congested Heart Failure (CHF), or those that have had Solid Organ transplants

*Compensation for time and travel may be available to those who qualify.